Innovation Alive and Well at Industry Conferences

This week, MDMA President and CEO, Mark Leahey attended the JP Morgan Healthcare Conference in San Francisco. The conference is a unique opportunity for industry leaders, emerging medical technology companies and entrepreneurs come together to deliver presentations to a global audience of 3,500 investors.  “It is clear that innovation is alive and well in the medical technology industry,” stated Leahey, “In 2010, MDMA will continue to focus on policies and legislation that promote innovation and ensure American's have timely access to safe and effective therapies."

In addition, Leahey spoke on a panel at the OneMedPlace Finance Forum, a conference designed to bring together life science companies and investors to help facilitate strategic partnerships.